E5 Ethnic Factors in the Acceptability of Foreign Clinical Data
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 10, 1998
April 29, 2020
41b52855-1683-45c6-8857-0b5935cfedc3
Related Documents
180-Day Generic Drug Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
Guidance DocumentJune 1, 1998Center for Drug Evaluation and Research
Q5D Quality of Biotechnological/Biological Products: Derivation and Characterization of Cell Substrates Used for Production of Biotechnological/Biological Products; Availability
Guidance DocumentSeptember 21, 1998Center for Drug Evaluation and Research
CVM GFI #135 Validation of Analytical Procedures for Type C Medicated Feeds
Guidance DocumentNovember 7, 2005Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox